T. Rowe Price Associates’s Stemline Therapeutics, Inc. STML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
2019
Q3
$1.84M Sell
2019
Q2
$11.6M Sell
2019
Q1
$11.5M Buy
2014
Q4
Sell
2014
Q3
$679K Sell
2014
Q2
$1.37M Sell
2014
Q1
$16.9M Sell
2013
Q4
$17.2M Sell
2013
Q3
$41.9M Sell
2013
Q2
$22.2M Buy